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In Brief
Changes in proteome and phos-
phoproteome have been deter-
mined in E. coli treated with the
antibiotics colistin or ciprofloxa-
cin and in a bona-fide mcr-1
positive colistin resistant strain.
The results reveal extensive
phosphorylation on bacterial
proteins and motif specific phos-
phorylation changes during re-
sistance development. Moreover,
regulated sites show high evolu-
tionary conservation, indicating
an important biological role. To-
gether, this indicates that phos-
phorylation mediated signaling
could be used as a specific tar-
get for drug design.
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A New Tool to Reveal Bacterial Signaling
Mechanisms in Antibiotic Treatment and
Resistance*□S
Miao-Hsia Lin‡§, Clement M. Potel‡§, Kamaleddin H. M. E. Tehrani¶,
Albert J. R. Heck‡§, Nathaniel I. Martin¶, and Simone Lemeer‡§
The rapid emergence of antimicrobial resistance is a ma-
jor threat to human health. Antibiotics modulate a wide
range of biological processes in bacteria and as such, the
study of bacterial cellular signaling could aid the develop-
ment of urgently needed new antibiotic agents. Due to the
advances in bacterial phosphoproteomics, such a sys-
temwide analysis of bacterial signaling in response to
antibiotics has recently become feasible. Here we present
a dynamic view of differential protein phosphorylation
upon antibiotic treatment and antibiotic resistance. Most
strikingly, differential phosphorylation was observed on
highly conserved residues of resistance regulating tran-
scription factors, implying a previously unanticipated role
of phosphorylation mediated regulation. Using the com-
prehensive phosphoproteomics data presented here as a
resource, future research can now focus on deciphering
the precise signaling mechanisms contributing to resist-
ance, eventually leading to alternative strategies to com-
bat antimicrobial resistance. Molecular & Cellular Pro-
teomics 17: 2496–2507, 2018. DOI: 10.1074/mcp.
RA118.000880.
Antimicrobial resistance (AMR)1 has become one of the
most serious threats to global health. At the rate at which
resistance against antibiotics is currently rising, it is not in-
conceivable that we will be confronted with a situation in
which the actual last resort antibiotics become ineffective. It is
estimated that AMR could cause 10 million deaths every year
by the year 2050 (1). In order to effectively combat the threat
of AMR, understanding of the molecular mechanisms under-
lying resistance acquisition is essential.
The noun antibiotic, first described in 1941 by Selman
Waksman, represents any small molecule made by a microbe
that inhibits the growth of other microbes (2), but an alterna-
tive view of antibiotics envisions them as signaling molecules
(3–5). The antibiotic colistin is a cationic cyclic decapeptide
with a lipophilic fatty acyl side chain that is used as a last
resort antibiotic for the treatment of multidrug resistant Gram-
negative infections (6). Alarmingly, a plasmid-mediated colis-
tin resistance mechanism (mcr-1 gene) has been reported in
over 30 countries across five continents since it was first
identified in 2015, raising major public health concern (7–9).
Ciprofloxacin is another critically important antimicrobial with
possible serious side effects (10) used to treat infections
resistant to safer antibiotics. Ciprofloxacin is one of the most
commonly prescribed fluoroquinolones in current medical
practice, and its resistance rate has raised from 1.8% to
15.9% over only 10 years (11). Overall, the worldwide spread
of AMR in recent years is a sobering reminder of our need to
better understand resistance mechanisms in order to design
new effective inhibitors.
While the characterization of resistance genes was already
made possible by advances in functional metagenomic ap-
proaches, these methods cannot quantify proteins and deci-
pher the potential bacterial signaling cascades involved in
AMR. The study of bacterial cellular signaling in AMR and
AMR acquisition could thus provide opportunities for the de-
velopment of new therapeutic strategies. Bacteria are capable
of modifying serine/threonine/tyrosine residues on proteins
like eukaryotes, but in addition use two-component signaling
that relies on histidine autophosphorylation of sensory ki-
nases as the first component and aspartate phosphorylation
of response regulators as the second component (12). Re-
versible protein phosphorylation is a well-established mech-
anism of regulating gene expression in response to a variety
of environmental stress factors (13) and in recent years, grow-
ing evidence has linked two-component systems as well as
serine/threonine/tyrosine kinase signaling to AMR (13–15).
While mass-spectrometry-based proteomics has enabled the
study of signaling dynamics on a global scale through the
quantification of site-specific protein phosphorylation in eu-
karyotes, the study of bacterial phospho-signaling has
largely lagged behind due to technical hurdles. Our recent
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developments in this area enable us to reach in-depth cov-
erage of bacterial phosphoproteomes (16, 17), offering the
unprecedented opportunity to study signaling mechanisms
during antibiotic treatment, resistance acquisition, and full
resistance.
Here we set out to detect changes in proteome and phos-
phoproteome of antibiotic-treated bacteria in order to detect
regulated expression and signaling that correlates with anti-
biotic susceptibility.
To this end we treated Escherichia coli with increasing
doses of ciprofloxacin or colistin for several days, in order to
decrease the susceptibility to the antibiotic. In the case of
colistin, we also analyzed the (phospho)proteome of a bona
fide, clinically isolated colistin resistant E. coli strain carrying
the mcr-1 plasmid. Our results indicate that antibiotic suscep-
tibility rapidly increases for ciprofloxacin treatment, coinciding
with extensive changes in phosphoproteome. For short-term
colistin treatment, changes in phosphoproteome resemble
the phosphoproteome of the bona fide mcr-1 positive strain,
despite the lack of a clear resistant phenotype, indicating that
changes in signaling precede resistance development.
MATERIALS AND METHODS
Bacterial Strains—Two E. coli strains were used in this study: the
wild-type E. coli strain W3110 (Coli Genetic Stock Center) and one
clinically isolated mcr-1 positive strain that carries the mcr-1-gene-
containing plasmid, conferring colistin resistance as the minimal in-
hibitory concentration (MIC) was 8 g/ml (experimentally determined).
This strain was isolated as part of routine diagnostic procedures in the
University Medical Center Utrecht (Utrecht, the Netherlands) from a
blood culture. This aspect of the study did not require consent or
ethical approval by an institutional review board. The MIC of cipro-
floxacin or colistin was determined by the dilution method in micro-
titer plates as previously described (18). For the E. coli W3110 wild-
type strain, the MIC for colistin and ciprofloxacin was experimentally
determined as 0.5 g/ml and 16 ng/ml, respectively.
Resistance Induction And Bacterial Cell Collections—An overnight
culture of wild-type E. coli strain was diluted 1:100 into Luria–Bertani
medium with or without 4 ng/ml ciprofloxacin, representing 1⁄4 the MIC
of ciprofloxacin. After 24 h of incubation at 37 °C with shaking, the
MIC was determined again. This same procedure was repeated until
the MIC of ciprofloxacin increased to 128 ng/ml (3 days) and 1,024
ng/ml (7 days) which are 8- and 64-fold higher than the original MIC.
The same approach was used for colistin in which the wild-type
E. coli cells were culture with Luria–Bertani medium with 1⁄4 the MIC of
colistin. However, no MIC increase was detected after 4 days up to 10
days of treatment. In order to detect the early response to colistin,
phosphoproteome analysis was further performed on the 4-day
treated E. coli. For all (phospho)proteomic analysis, 1 ml of culture
was transferred to 100 ml culture medium including antibiotics. E. coli
was subsequently grown to early-stationary phase (OD600 1.2) after
which samples for proteome and phosphoproteome analyses were
collected. Briefly, bacterial cells were collected by centrifugation at
3,000 g at 4 °C for 15 min. The cell pellets were washed twice with
ice-cold PBS and stored at 80 °C until further processes.
Cell Lysis And Protein Extraction—All different E. coli cells with
varied MICs to ciprofloxacin or colistin were lysed as described
previously (16, 17). Briefly, cell pellets were resuspended with lysis
buffer (100 mM Tris-HCl, pH 8.5, 7 M urea, 1% sodium deoxycholate
(Sigma-Aldrich, Steinheim, Germay), 5 mM tris(2-carboxyethyl)phos-
phine, 30 mM 2-chloroacetamide, 10 U/ml DNase I, 1 mM magnesium
chloride (Sigma Aldrich), 1% benzonase (Merck Millipore, Darmstadt,
Germany), phosphoSTOP (Roche, Basel, Switzerland), and complete
mini EDTA free (Roche)) and lysed by sonication for 45 min (20 s on,
40 s off) using a Bioruptor Plus. Cell debris was removed by ultra-
centrifugation (140,000 g for 1 h at 4 °C). 1% benzonase was added
to the supernatant, and the mixture was incubated at room temper-
ature for 2 h. Protein concentration was determined by a Bradford
protein assay (Bio-Rad, CA) using bovine serum albumin as the
protein standard. Impurities were removed by methanol/chloroform
protein precipitation as follows: 1 ml of supernatant was mixed with 4
ml of methanol (Sigma-Aldrich), 1 ml chloroform (Sigma-Aldrich) and
3 ml ultrapure water with thorough vortexing after each addition. The
mixture was then centrifuged for 10 min at 5,000 rpm at room tem-
perature. The upper layer was discarded, and 3 ml of methanol was
added. After sonication and centrifugation (5,000 rpm, 10 min at room
temperature), the solvent was removed and the precipitate was al-
lowed to air dry. The pellet was resuspended in a buffer composed of
100 mM Tris-HCl, pH 8.5, 1% sodium deoxycholate, 5 mM tris(2-
carboxyethyl)phosphine, and 30 mM 2-chloroacetamide. Trypsin
(Sigma-Aldrich) and Lys-C (Wako, VA) proteases were respectively
added to a 1:25 and 1:100 ratio (w/w), and protein digestion was
performed overnight at room temperature.
Peptide Desalting—The tryptic peptide mixtures were acidified to
pH 3.5 with 10% formic acid (Sigma-Aldrich) and centrifuged at
14,000 rpm for 10 min at 4 °C. The supernatant was then loaded on
a 200 mg (3cc) tC18 Sep-Pak resin (Waters, MA), washed with 2  1
ml of 0.1% formic acid, and peptides were eluted with 30% acetoni-
trile (Sigma). Eluted peptides were subsequently dried down using a
lyophilizer and subjected to proteome analysis or phosphopeptide
enrichment.
Fe3-IMAC Phosphopeptide Enrichment—Enrichments were per-
formed as previously described (17). Briefly, lyophilized peptides were
dissolved in buffer containing 30% acetonitrile and 0.07% trifluoro-
acetic acid (TFA, Sigma-Aldrich)), and the pH was adjusted to a value
of 2.3 using 10% TFA prior to injection onto the Fe3-IMAC column
(Propac IMAC-10 4  50 mm column, Thermofisher Scientific). The
elution buffer is composed of 0.3% NH4OH. UV-abs signal was
recorded at the outlet of the column, at a wavelength of 280 nm.
Collected phosphopeptides were immediately frozen in liquid nitro-
gen and subsequently dried down using a lyophilizer.
LC-MS/MS—Nanoflow LC-MS/MS analysis was performed by
coupling an Agilent 1290 (Agilent Technologies, Middelburg, Nether-
lands) to an Orbitrap Q- Exactive HF (Thermo Scientific, Bremen,
Germany). Lyophilized peptides were dissolved in loading buffer (10%
formic acid (FA) in the case of proteome samples and 20 mM citric
acid (Sigma-Aldrich) complemented with 1% formic acid in the case
of phosphoproteome samples) and injected, trapped and washed on
a pre-column (100 m inner diameter  2 cm, packed with 3 m C18
resin, Reprosil PUR AQ, Dr. Maisch, Ammerbuch-Entringen, Ger-
many, packed in-house) for 5 min at a flow rate of 5 l/min with 100%
buffer A (0.1% FA, in HPLC-grade water). Peptides were then trans-
ferred to an analytical column (75 m 60 cm Poroshell 120 EC-C18,
2.7 m, Agilent Technology, packed in-house) prior to separation at
room temperature at a flow rate of 300 nl/min using a 115-min linear
gradient, from 13% to 44% buffer B (0.1% FA, 80% acetonitrile
(ACN)). Electrospray ionization was performed using 1.9-kV spray
voltage and a capillary temperature of 320 °C. The mass spectrom-
eter was operated in data-dependent acquisition mode: full scan MS
1 The abbreviations used are: AMR, antimicrobial resistance; IMAC,
immobilized metal ion affinity chromatography; mcr-1, mobilized
colistin resistance gene; MIC, minimal inhibitory concentration; LC,
liquid chromatography; GO, gene ontology.
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spectra (m/z 375–1,600) were acquired in the Orbitrap at 60,000
resolution for a maximum injection time of 20 ms with an automatic
gain control (AGC) target value of 3e6. Up to 12 precursors were
selected for subsequent fragmentation and high-resolution higher
energy collision-induced dissociation MS2 spectra were generated
using a normalized collision energy of 27%. The intensity threshold to
trigger MS2 spectra was set to 2e5, and the dynamic exclusion to
15 s. MS2 scans were acquired in the Orbitrap mass analyzer at a
resolution of 30,000 (isolation window of 1.4 Th) with an AGC target
value of 1e5 charges and a maximum ion injection time of 50 ms.
Precursor ions with unassigned charge state as well as charge state
of 1 or superior/equal to 6 were excluded from fragmentation.
Data Analysis—MaxQuant software (version 1.6.0.1) was used to
process the raw data files, which were searched against the database
merging reviewed E. coli K12 sequences (E. coli K12 Uniprot data-
base, March 2016, 4,434 entries) and mcr-1 strain sequences (5,005
entries) and removing duplicates, with the following parameters: tryp-
sin digestion (cleavage after lysine and arginine residues, even when
followed by proline) with a maximum of three missed cleavages, fixed
carbamidomethylation of cysteine residues, and variable modifica-
tions of methionine oxidation and protein N-terminal acetylation (19).
In case of phosphoproteome analysis, the variable modification of
phosphorylation on serine, threonine, tyrosine, histidine, and aspar-
tate residues was also included. Mass tolerance was set to 4.5 ppm
at the MS1 level and 20 ppm at the MS2 level. The false discovery rate
was set to 1% at the peptide and protein level, an additional peptide
score cutoff of 40 was used for modified peptides, and the minimum
peptide length was set to seven residues. In terms of label-free
quantification analysis, the match between runs function was used
with the retention time window of 1 min. The MaxQuant output tables
“evidence.txt” and “phospho (HDSTY)Sites.txt” from phosphopro-
teome dataset and “proteinGroups.txt” from proteome datasets were
further used to calculate the identification number of unique phos-
phopeptides, phosphosites, and proteins. The table of phospho
(HDSTY)Sites.txt and “proteinGroups.txt” were further used for quan-
tification analysis at phosphoproteome and proteome level, respec-
tively, using Perseus (version 1.6.0.2) (20). Known contaminants as
provided by MaxQuant and identified in the samples were excluded
from the analysis. The list of modified peptides was further filtered at
the level of phospho-site localization using a localization probability
threshold of 0.75 to derive all class I phospho-sites. To determine
phosphorylation sites corresponding to dynamic profiles due to
changes in phosphorylation state rather than protein abundance, we
normalized the phosphosite level by the corresponding changes in
protein abundance. To detect the complete matrix of intensities for
on/off regulation in quantification analysis, missing value imputation
was performed when all three values existed in at least on condition.
The log2 scale of phosphosites or proteins intensity were subjected
into a two-way analysis of variance test with a false discovery rate of
less than 0.05.
Bioinformatic Analysis—The Gene Ontology (GO) analysis was per-
formed with PANTHER (http://www.pantherdb.org/), with p value 
0.05. The KEGG pathway enrichment was performed using ClueGO
app in Cytoscape (version 3.5.1) with the p value 0.05 (21). Phos-
phorylation motifs were analyzed using the Motif- algorithm with
occurrences set to 10 and significance set to 0.00001, using the
whole genome sequence as background (22). Sequence logos were
generated by iceLogo (23). For protein sequence alignment, full-
length protein sequences were aligned using the Clustal X program
with default settings and after alignment, phosphosite regions were
displayed. All protein sequences from the same gene in different
Gram-negative bacteria, relatively close to E. coli., were download
from Uniprot.
Experiment Design and Statistical Rationale—Each sample was
enriched in triplicate before being injected separately into the LC-
MS/MS system. Each raw file was separately processed using the
MaxQuant software. Triplicate analysis was sufficient to saturate the
number of phosphosites detected.
RESULTS
Proteome Profiling Demonstrates Differential Protein Ex-
pression Triggered by Continuous Exposure to Antibiotics—
Wild-type E. coli cells were continuously exposed to low dos-
age, corresponding to one-quarter of the MIC, of either
colistin or ciprofloxacin to decrease the antibiotic susceptibil-
ity and trigger AMR (Fig. 1A). For ciprofloxacin, we indeed
observed a rapid increase in MIC, resulting in an eightfold higher
MIC after 3 days and a 64-fold higher MIC after 7 days (Fig. 1A).
For colistin, we did not observe a higher MIC after 4 days nor at
10 days of treatment, indicating a clear difference in response to
the antibiotics used (Fig. 1A, supplemental Fig. 1A).
To comprehensively survey cellular signaling at early stages
of antibiotic treatment and early resistance development, la-
bel-free quantification of both proteome and phosphopro-
teome was performed (supplemental Fig. 1). Due to the lack of
a clear resistant phenotype at 10 days of colistin treatment,
we focused our (phospho)proteome analysis to the 4-day time
point in order to get insight into the early onset effects of
colistin treatment. At a false discovery rate of 1% at the
protein level, this resulted in the identification of 2,850 pro-
teins (supplemental Table 1), from which 2,567 were quanti-
fied, achieving a similar coverage as previous E. coli pro-
teome studies but within a significant shorter analysis time
(24). Moreover, similar GO profiles were obtained at the pro-
teome and genome levels, confirming the completeness of
our proteome coverage (supplemental Fig. 2). We next eval-
uated these protein expression patterns to detect differential
expression related to antibiotic treatment and resistance.
Principle component analysis of colistin and ciprofloxacin
proteome data clearly segregated samples into three groups.
Furthermore, the analysis indicated that the serially passaged
E. coli treated with a low dose of colistin are closer related to
mcr-1-positive cells than to untreated cells, despite the lack
of a clear resistant phenotype in serially passaged colistin
treated E. coli (Fig. 1A and 1B). As expected, the phosphoe-
thanolamine transferase coded by mcr-1 was only identified in
the mcr-1 clinical strain (Fig. 1C). Surprisingly, several classes
of proteins known to be involved in resistance exhibited sig-
nificant changes in expression upon colistin treatment as well
as in the mcr-1 cells. The multidrug efflux pump (AcrA) as well
as a variety of proteins involved in cell wall biogenesis, such
as the Bam protein complex (25), LPS assembly outer mem-
brane protein LptE (26), and the peptidoglycan biosynthesis
proteins (MltA and MltB) (27) were more expressed in colistin
serially passaged as well as in mcr-1 cells (Fig. 1C and sup-
plemental Table 2). Furthermore, the glycolysis/gluconeogen-
esis pathway and protein translation were down-regulated for
both treated and resistant cells, which is consistent with the
Phosphoproteomic Profiling During Antimicrobial Resistance
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FIG. 1. Quantitative proteomic analysis of E. coli continuously exposed to colistin or ciprofloxacin. (A) Wild-type E. coli cells were
continuously exposed to the antibiotics colistin or ciprofloxacin with the concentration being one quarter of the MIC. No MIC increase was
noticed after 4 days of exposure to colistin, while the clinically isolated mcr-1 strain exhibited a MIC of 8 g/ml. However, after three and 7
days of exposure to ciprofloxacin, the MIC increased eightfold (128 ng/ml) and 64-fold (1,024 ng/ml), respectively. (B, C) Principle component
analysis shows that the three replicates cluster together, indicating good reproducibility. (B) Pink circles represent the control wild-type E. coli
Phosphoproteomic Profiling During Antimicrobial Resistance
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concept of compensatory fitness cost in developing resist-
ance (28, 29) (Fig. 1C and supplemental Table 2).
For induced ciprofloxacin resistance, similar regulation pat-
terns were observed, as expression levels of lipoproteins (n 
22) or proteins involved in cell wall biogenesis (n 21) and cell
cycle (n  19) were highly increased when antibiotic suscep-
tibility decreased (Fig. 1D and supplemental Table 2). In
agreement with ciprofloxacin targeting DNA gyrase activity, a
significant number of DNA repair system proteins (n  21)
were increasingly expressed when resistance developed (Fig.
1D and supplemental Table 2). Compared with colistin, cip-
rofloxacin induced the expression of a different panel of mul-
tidrug efflux system proteins, including MdtK, EmrA, SbmA,
and MdlA proteins, which can be explained by the different
nature of both antibiotics.
Bacterial Protein Phosphorylation Is Far More Widespread
Than Anticipated—Bacteria, as well as other organisms, have
developed several phosphorylation-dependent systems to
adapt to environmental stresses, including the well-known
two-component system, which constitutes one of the most
sensitive and efficient regulatory mechanisms in bacteria. To
get detailed insight into differential phosphorylation associ-
ated with antibiotic treatment, changes in antibiotic suscep-
tibility, and resistance, we subsequently profiled the phospho-
proteomes of all samples (supplemental Fig. 1). Our analysis
resulted in the identification of 2,509 class I phosphosites
(unambiguously localized) on 1,133 proteins (supplemental
Table 3). In contrast to commonly used phosphoproteomics
workflows, which are usually based on the combination of
fractionation and phosphopeptide enrichment (30, 31), all ex-
periments here were performed in triplicate, which was suffi-
cient to saturate the number of sites (supplemental Fig. 3) with
high quantification accuracy and reproducibility (Pearson cor-
relation coefficient between 0.982 and 0.919, supplemental
Fig. 4). In total, we quantified 3,872 phosphopeptides, which
span around four orders magnitude of peptide ion signal,
allowing us to look beyond classically observed phosphory-
lations on high abundant metabolic enzymes (Fig. 2A). In fact,
phosphorylation events on several transcription factors and
those indicating kinase activity were identified in the lowest-
abundance range of the distribution We therefore hypothe-
sized that the dynamics of phosphorylation signaling net-
works induced by antibiotics could be well profiled (Fig. 2A).
The comprehensive and parallel measurements of phospho-
proteome and proteome allowed us, for the first time, to
investigate a possible correlation between a protein’s abun-
dance and its propensity to be phosphorylated. There is a
weak but significant tendency between the number of identi-
fied phosphosites and increasing protein abundance (Fig. 2B,
Pearson correlation as 0.65, p  0.01), which is similar to the
profile in the human phosphoproteome (32). About 45% of
identified proteins were phosphorylated on just one residue,
whereas the remaining 55% were phosphorylated at multiple
sites (Fig. 2C). In addition, the GO term enrichment of identi-
fied phosphorylated proteins correlates with the obtained pro-
teome profile, suggesting that we achieved a comprehensive
phosphoproteome coverage (supplemental Fig. 2). Moreover,
the residue-specific phosphorylation pattern observed (Ser
56%, Thr 20%, Tyr 13%, Asp 5%, and His 5%; Fig. 2D)
closely corresponds to previously published reports (33).
When compared with the two existing databases, dbPSP and
Uniprot, the work described here expands the known E. coli
phosphoproteome by a factor of 4, and as a result, 89.6% of
identified phosphosites (n 2,248) were observed for the first
time (Fig. 2E) (34). Overall, this work indicates that bacterial
phosphorylation is far more widespread than anticipated, as
40% of the identified proteins are phosphorylated.
In-depth Quantitative Phosphoproteomics Enables Identifi-
cation of Potential Regulators in Resistance Development—
Principal component analysis of the phosphoproteome data
again segregated the E. coli cells according to antibiotic sus-
ceptibility (Fig. 3A and 3B). For ciprofloxacin, phosphopro-
teomes of 7-day-treated cells were more distinct from the
3-day-treated and nontreated cells. Surprisingly, for colistin,
the 4-day-treated cells resembled the resistant mcr-1 cells,
again despite the presence of a clear resistant phenotype but
in accordance with the proteome data. These results suggest
that specific regulation at the phosphorylation level takes
place upon antibiotics treatment, driving to a resistance-like
phenotype (Fig. 3A). Indeed, a high percentage of identified
phosphosites showed significant differential regulation during
treatment and resistance: 460 phosphosites were significantly
regulated in the colistin samples, while 911 were regulated
upon ciprofloxacin treatment (analysis of variance test, false
discovery rate  0.05; supplemental Table 4).
When looking closely at the significantly regulated phos-
phosites, we identified phosphorylation changes on several
known resistance-related proteins. We observed increased
phosphorylation of His717 on the ArcB sensor protein upon
colistin treatment, a finding that is in agreement with previous
W3110 strain without colistin treatment. The purple circles represent the 4 days colistin treated E. coli cells, blue circles represent the mcr-1
E. coli strain. This analysis of protein expression patterns clearly showed that colistin treated E. coli cells were closer to the mcr-1 strain. (C)
Purple and violet circles are representing E. coli cells harvested after 3 days or 7 days of ciprofloxacin treatment, respectively and brown circles
represent the nontreated control. For ciprofloxacin, E. coli cells with an induced higher MIC (day 3, day 7) showed different patterns compared
with nontreated E. coli cells. (D, E) Unsupervised clustering analysis of the changes in the proteome following induction of resistance to (D)
colistin and (E) ciprofloxacin. The color code shows the relative abundance based on the Z-score. On the right, for each box that is highlighted
in the cluster analysis, the enriched pathways are displayed. Proteins that belong to a specific cluster and participate in a certain pathway are
indicated by their gene names. The pathway enrichment was performed using PANTHER (p values 0.05).
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studies showing that colistin stimulates the production of
highly deleterious hydroxyl radicals, inducing high activity of
the ArcAB two-component system as a resistance mecha-
nism (35, 36). Phosphorylation levels of proteins involved in
DNA transfer (relaxosome proteins: TraD, TraP) and integra-
tion host factor (IhfA)) (37), universal stress proteins (UspB
and UspG) (38), Psp system (PspA and PspC) (39), and drug
efflux proteins (OmpT) (40) were also regulated in the colistin
serially passaged E. coli (Fig. 3C and supplemental Table 4).
Similarly, differential phosphorylation of known resistance-
related proteins was observed upon ciprofloxacin treatment
(Fig. 3D and supplemental Table 4), for example on the DNA
transfer-related proteins (TraM, IhfA, and IhfB), stress re-
sponse proteins (UspA, UspF, and UspG) (38), psp system
(PspA) (39), and the antibiotics-degrading enzyme AmpC.
Interestingly, phosphorylation of several DNA repair proteins
(UvrA, UvrB, and UvrC) was significantly down-regulated in
ciprofloxacin-resistant cells, implying that these phosphoryl-
ation events play a role in combating the effect of ciprofloxa-
cin, which is a DNA gyrase inhibitor (Fig. 3D). ABC transporter
and two-component system pathways, which are known to
be related to evolution of resistance (14, 41), were significantly
regulated in both colistin and ciprofloxacin treatments (Fig. 4).
Though signal transduction via two-component systems is
known to rely on reversible phosphorylation (12), regulated
phosphosites identified here are mostly unknown, suggesting
that the detailed signaling mechanisms underlying response
and resistance to antibiotics are currently underestimated.
FIG. 2. Comprehensive profiling of the E. coli phosphoproteome. (A) Dynamic range of the quantifiable phosphopeptides with the
corresponding overrepresented biological process GO terms. GO term enrichment was performed using PANTHER (http://www.pantherdb.org/)
with p value  0.05. (B) Correlation between the number of phosphosites per protein and protein abundance shows there is a weak correlation
(Pearson correlation is 0.65). The color code indicates the protein abundance at log10 scale. (C) Characterization of the phosphoproteins based on
the number of phosphosites indicated that most of the proteins, around 45%, only have one phosphosite. (D) Phosphosite distribution across
S/T/Y/H/D residues. (E) The overlap between phosphosites identified in this study and public databases, dbPSP and Uniprot, showing the up to
89.6% of phosphosites identified in this study are novel phosphosites.
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Furthermore, we identify for the first time enriched phos-
phorylation motifs in different regulatory clusters, implying
that specific kinase/phosphatase systems are involved in an-
tibiotic response and resistance (Fig. 3C and 3D). As an
example, we observed the motif KxxS, matching to the HipA
kinase’s substrate motif, on Ser239 of the GltX protein. Inter-
estingly, the HipA kinase was phosphorylated at both Ser150
and Asp146, albeit respectively up- and down-regulated dur-
ing antibiotic treatment, suggesting that those two phospho-
sites may play a role in the regulation of the kinase function
during resistance development (42). In addition, several spe-
cific tyrosine phosphorylation motifs were identified, suggest-
ing the potential importance of tyrosine kinase-induced phos-
phorylation in resistance evolution (Fig. 3C and 3D). Protein
phosphorylation occurring in the proximity of the protein N- or
C terminus was highly enriched, consistent with findings in a
previous study (33). We here demonstrate the possible impor-
tance of these terminal phosphorylation events in resistance
development (Fig. 3C and 3D). As such terminal phosphor-
ylation events are possibly bacteria specific, the kinases re-
FIG. 3. Phosphoproteomes of E. coli changes extensively upon colistin and ciprofloxacin treatment. As observed for the proteome
analysis, triplicate phosphoproteomics samples clustered well together. (A) The pink circles represent the control E. coli W3110 strain without
colistin treatment, whereas purple circles represent data from the serially passaged wile-type E. coli cells treated with colistin. Blue circles
represent data from the mcr-1 E. coli strain. Colistin-treated wild-type E. coli cells are in this analysis closer to the mcr-1 strain, suggesting that
common resistance mechanisms are partially shared. (B) For ciprofloxacin treatment, brown circles represent the control wild-type E. coli
W3110 strain without ciprofloxacin treatment and purple and violet circles are representing the E. coli cells harvested after 3 days or 7 days
treatment with ciprofloxacin, respectively. (C, D) Heatmap clustering of phosphorylation profiles after (C) colistin and (D) ciprofloxacin
treatment. Each box represents a distinct unsupervised cluster profile across the different antibiotic susceptibilities. The color scale from blue
to red indicates the Z-score, indicating decreased and increased phosphorylation. Regulated phosphosites in known resistance-related
pathways are shown in the middle. Enriched phosphorylation motifs within particular clusters are displayed on the right, implicating that some
specific kinases are involved in regulation. X was used to represent the N- or C-terminal position but not any particular amino acid. N-terminal
phosphorylation was overrepresented in both treatments, while the C-terminal phosphorylation is only regulated in ciprofloxacin treatment.
Three tyrosine phosphorylation motifs were enriched as well as four basophilic motifs.
FIG. 4. KEGG pathway enrichment analysis based on regulated phosphosites containing proteins from both colistin and ciprofloxa-
cin treatments. (A) In total, 555 phosphoproteins were subjected to KEGG pathway enrichment using Cytoscape with the ClueGO app. The
pathways shown here are significantly enriched with p value  0.05. Black circles represent the phosphoproteins containing regulated
phosphosites, while the colored ellipses represent each overrepresented pathways. Proteins inside overlapping pathways indicate that these
proteins are involved in multiple pathways. (B) The regulated phosphosites identified in ABC transporter and two component system upon
colistin (blue circle) and ciprofloxacin (brown circle) treatments (green: down-regulated, pink: up-regulated).
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sponsible for these phosphorylations could represent ade-
quate drug targets.
Regulated Phosphosites Involved in DNA Transcription Dis-
play Evolutionary High Conservation Across Bacterial Spe-
cies—Phosphorylation on DNA transcriptional regulators is of
particular interest because of its potential to influence bacte-
rial cell growth and pathogenicity (13). This spurred us to
assess the residue conservation among regulated phospho-
sites identified on known transcription factors, as a high level
of conservation can indicate conserved biological function
(13). Among identified regulated phosphosites, several resi-
dues on winged helix-turn-helix DNA-binding domains were
highly conserved in proteobacteria. This includes residues on
the C-terminal effector domain of the OmpR/PhoB subfamily
transcription regulators such as Thr191, His200, and Ser202
residues on CpxR and Tyr194 on OmpR, and Ser214 and
Tyr226 on BaeR (Fig. 5). Other evolutionary conserved phos-
phosites on helix-turn-helix domains were observed at
Thr141, Ser180, and Thr209 of Crp as well as on Thr2 of the
AscG transcription regulator (Fig. 5). Our data thus suggest
that protein phosphorylation in the helix-turn-helix region
might be a widespread mechanism of transcriptional control
of genes implicated in antibiotic resistance.
Phosphosites identified on transcription regulators such as
Tyr64 and Tyr 146 on RcsB; Ser282 on CysB; Ser3 on SlyA;
Thr62, Thr126, Ser129, and Ser135 on YebC; and His230 on
YeiE were also found to be highly conserved among bacterial
orthologues (supplemental Fig. 5). The observed up-regula-
tion of the conserved transcriptional regulatory protein RcsB
phosphosites, Tyr64 and Tyr146, for colistin serially passaged
cells is consistent with previous reports establishing a link
between the RcsCDB/F phospho-relay system and polymyxin
resistance (43). In the same manner, high conservation of
phosphorylated residues was found on other DNA-binding
proteins, including Hns, StpA, HupA, and HupB, in which
regulated phosphosites located both on DNA-binding or pro-
tein dimerization domains were found to be all highly con-
served across bacteria (Fig. 6). Interestingly, the hns protein
has been linked to multidrug resistance (44) and together with
protein StpA coordinates OmpF porin gene expression and
DNA conjugation in order to cope with environmental stress
such as antibiotic administration (45, 46). In addition, histone-
FIG. 5. Observed phosphosites are highly conserved on the helix-turn-helix regions of several transcription factors as revealed by
sequence alignment across different bacteria. (A–C) Alignment of regulated phosphosites in the OmpR/PhoB subfamily transcription
factors, including the Y194 on OmpR, H200 and S202 on CpxR, and S214 and Y226 on BaeR. (D, E) Alignment of phosphorylated residues
on the non-OmpR/PhoB subfamily transcription factors, which are T141, S180, and T209 on Crp and T2 on AscG. These phosphosites have
high conservation across different bacteria indicating a possible conserved role in regulations. Sequence alignment was performed with Clustal
X with default parameters. The purple boxes represent the phosphosites identified in this study.
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like proteins HupA and HupB are the most common bacterial
DNA-binding proteins responsible for nucleoid compaction;
therefore, dynamic phosphorylation events located on DNA-
binding region and the N-terminal tail might be similar to
eukaryotic histones phosphorylations and serve as sensors of
cellular stress, ultimately leading to resistance-related gene
expression (47). Therefore, the well-known eukaryotic his-
tone-code may have a prokaryotic counter-part.
DISCUSSION
The concept that regulated protein phosphorylation in its
various facets could contribute to defining new drug targets is
not new per se. However, the thorough investigation of phos-
phorylation signaling pathways in bacteria has been mostly
neglected. Here we present the broadest bacterial phosphor-
ylation catalogue, representing 2,509 phosphosites. Notably,
the extent of phosphorylation regulation in bacteria is far more
important than we anticipated, and the fact that only 10.4% of
identified phosphosites (n  261) are reported in the public
databases, Uniprot and dbPSP, make this study a valuable
resource for future, indispensable work on deciphering sig-
naling mechanisms involved in AMR.
We showed for the first time that specific phosphorylation
motifs changed during resistance development. This is con-
sistent with the idea that bacterial Ser/Thr/Tyr kinases are
involved in resistance development (48), which has been pro-
posed but never comprehensively studied. Moreover, regu-
lated phosphorylation sites located on transcription factors
and other DNA-binding proteins showed high evolutionary
conservation, indicating an important biological role. Finally,
upon resistance development, we also observed specific reg-
ulation of N/C-terminal phosphorylation, which is unique to
bacteria. Together, these regulated phosphorylation events
during antibiotic treatment and resistance indicate that phos-
phorylation mediated signaling could be used as a specific
target for drug design. In summary, we here describe the most
comprehensive coverage of a bacterial phosphoproteome
and monitor its dynamics upon perturbation by antibiotics.
The unprecedented depth of our phospho-analysis, as well as
the fact that significant reversible phosphorylation re-
sponses are observed upon antibiotic treatment opens up
new avenues for research into novel alternative strategies to
combat AMR. Future work should be aimed at understand-
ing the contribution of each signaling pathway to resistance
development.
Acknowledgments—We acknowledge Willem van Schaik and Axel
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FIG. 6. Observed phosphosites are highly conserved in a variety of DNA-binding proteins across different bacteria. The phosphosites
identified on DNA binding proteins (in purple boxes) include (A) T13, S45, Y97, T106, T115, and S129 on Hns, (B) S79, T100, and T106 on StpA,
(C) T70 on HupB, and (D) T4 and T19 on HupA. Although S45 on Hns and T70 on HupB display slightly lower conservation, the high prevalence
of acidic amino acids instead of Ser or Thr may reflect the fact that the negative charge is essential for protein functions.
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